Importantly, it is shown that ATG4B‐mediated DNA repair defects are significantly enhanced in patient‐derived acute myeloid leukemia (AML) cells and in mouse AML cells induced by MLLT3‐KMT2A overexpression. The gene discussed is ATG4B; the disease is acute myeloid leukemia.